Process for the preparation of enantiomerically pure NmethylN- [(1S)-phenyl-2-((3S)-3-hydroxypyrrolidin -1-yl)ethyl]-2,2-diphenylacetamide
Details for Australian Patent Application No. 2003248428 (hide)
International Classifications
Event Publications
9 October 2003 Complete Application Filed
16 October 2003 Complete Application Filed
6 November 2003 Application Open to Public Inspection
Published as AU-B-2003248428
13 November 2003 Section 223 Application Allowed
Merck Patent GmbH The time in which to make a further application for a divisional patent has been extended to 05 Oct 2003. Address for service in Australia - Davies Collison Cave Level 10 10 Barrack Street Sydney NSW 2000
20 October 2005 Application Accepted
Published as AU-B-2003248428
16 February 2006 Standard Patent Sealed
10 May 2007 Assignment Registered
Merck Patent GmbH The patent has been assigned to Tioga Pharmaceuticals, Inc. Notice of Intention to Amend Complete Specification of Patent Application pursuant to Order 58 Rule 10(1) of the Federal Court Rules
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser